Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NovaBay Pharmaceuticals (NBY) Assets Average (2016 - 2025)

Historic Assets Average for NovaBay Pharmaceuticals (NBY) over the last 17 years, with Q3 2025 value amounting to $5.2 million.

  • NovaBay Pharmaceuticals' Assets Average rose 3327.35% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 3327.35%. This contributed to the annual value of $6.2 million for FY2024, which is 5102.03% down from last year.
  • Per NovaBay Pharmaceuticals' latest filing, its Assets Average stood at $5.2 million for Q3 2025, which was up 3327.35% from $8.4 million recorded in Q2 2025.
  • NovaBay Pharmaceuticals' 5-year Assets Average high stood at $24.4 million for Q1 2022, and its period low was $3.6 million during Q4 2024.
  • Moreover, its 5-year median value for Assets Average was $13.8 million (2021), whereas its average is $12.9 million.
  • In the last 5 years, NovaBay Pharmaceuticals' Assets Average tumbled by 7296.6% in 2024 and then surged by 8081.23% in 2025.
  • Over the past 5 years, NovaBay Pharmaceuticals' Assets Average (Quarter) stood at $18.1 million in 2021, then increased by 7.06% to $19.4 million in 2022, then tumbled by 43.56% to $10.9 million in 2023, then tumbled by 66.65% to $3.6 million in 2024, then surged by 42.44% to $5.2 million in 2025.
  • Its Assets Average stands at $5.2 million for Q3 2025, versus $8.4 million for Q2 2025 and $6.6 million for Q1 2025.